Calumet, Inc. /DE (CLMT) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$5.40M*; Operating income -$40.00M; Depreciation and amortization $34.60M*.
- 2026-03-31: Basis Reported; EBITDA -$138.3M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $322.90M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA -$64.30M*; Operating income -$101.00M; Depreciation and amortization $36.70M*.
Complete source-backed ebitda history.
- Available history
- 2022-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$5.40M* | -$40.00M | $34.60M* | $1.45B | -0.37%* | $38.30M* | $92.30M* | $1.43B | (m) | (m) | -$21.20M |
|---|
| 2026-03-31 | Reported | -$138.3M | (m) | (m) | (m) | -13.43% | $13.20M | -$86.20M | $1.12B | (m) | (m) | -$20.80M |
|---|
| 2025-09-30 | Reported | (m) | $322.90M | (m) | $1.08B | (m) | $8.40M* | $23.50M* | $704.30M | (m) | (m) | -$41.40M |
|---|
| 2025-06-30 | Reported | -$64.30M* | -$101.00M | $36.70M* | $1.03B | -6.26%* | $13.60M* | -$1.80M* | $1.07B | (m) | (m) | $200.00K |
|---|
| 2025-03-31 | Reported | -$11.7M | (m) | (m) | (m) | -1.18% | $17.60M | -$29.30M | $1.08B | (m) | (m) | $400.00K |
|---|
| 2024-09-30 | Reported | (m) | -$57.10M | (m) | $1.10B | (m) | $16.70M* | -$15.50M* | $1.10B | (m) | (m) | $700.00K |
|---|
| 2024-06-30 | Reported | (m) | $6.20M | (m) | $1.13B | (m) | $15.00M* | $66.50M* | $1.07B | (m) | (m) | $500.00K |
|---|
| 2024-03-31 | Reported | (m) | $36.30M | (m) | $1.01B | (m) | $20.00M | -$94.00M | $927.30M | (m) | (m) | $200.00K |
|---|
| 2023-09-30 | Reported | (m) | $213.00M | (m) | $1.15B | (m) | (m) | (m) | $887.90M | (m) | (m) | $500.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $257.5M | (m) | (m) | (m) | 6.22% | $52.30M | $108.90M | $3.89B | (m) | (m) | -$92.60M |
|---|
| 2024-12-31 | Reported | $157.1M | (m) | (m) | (m) | 3.75% | $76.70M | -$46.40M | $3.96B | (m) | (m) | $800.00K |
|---|
| 2023-12-31 | Reported | $414M | (m) | (m) | (m) | 9.90% | $271.80M | -$14.90M | $3.73B | (m) | (m) | $1.60M |
|---|
| 2022-12-31 | Reported | $230.2M | (m) | (m) | (m) | 4.91% | $536.20M | $100.60M | $4.33B | (m) | (m) | $3.40M |
|---|